PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-23.83%
Negative revenue growth while EXP stands at 34.99%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-41.87%
Negative gross profit growth while EXP is at 77.42%. Joel Greenblatt would examine cost competitiveness or demand decline.
-97.12%
Negative EBIT growth while EXP is at 84.68%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-98.37%
Negative operating income growth while EXP is at 93.86%. Joel Greenblatt would press for urgent turnaround measures.
-112.82%
Negative net income growth while EXP stands at 85.56%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-114.56%
Negative EPS growth while EXP is at 88.06%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-114.71%
Negative diluted EPS growth while EXP is at 88.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.25%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.02%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
5.91%
Dividend growth above 1.5x EXP's 1.15%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-124.14%
Negative OCF growth while EXP is at 117.68%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-172.97%
Negative FCF growth while EXP is at 318.59%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
15.40%
10Y revenue/share CAGR under 50% of EXP's 239.77%. Michael Burry would suspect a lasting competitive disadvantage.
15.40%
5Y revenue/share CAGR under 50% of EXP's 88.22%. Michael Burry would suspect a significant competitive gap or product weakness.
15.40%
3Y revenue/share CAGR under 50% of EXP's 31.63%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-7.82%
Negative 10Y OCF/share CAGR while EXP stands at 911.08%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-7.82%
Negative 5Y OCF/share CAGR while EXP is at 81.96%. Joel Greenblatt would question the firm’s operational model or cost structure.
-7.82%
Negative 3Y OCF/share CAGR while EXP stands at 27.46%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-268.56%
Negative 10Y net income/share CAGR while EXP is at 398.35%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-268.56%
Negative 5Y net income/share CAGR while EXP is 62.76%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-268.56%
Negative 3Y CAGR while EXP is 36.78%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
12.03%
Below 50% of EXP's 117.10%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
12.03%
Below 50% of EXP's 77.31%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
12.03%
Below 50% of EXP's 54.55%. Michael Burry suspects a serious short-term disadvantage in building book value.
-64.08%
Cut dividends over 10 years while EXP stands at 150.57%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-64.08%
Negative 5Y dividend/share CAGR while EXP stands at 151.67%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-64.08%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
6.66%
AR growth is negative/stable vs. EXP's 19.08%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
4.31%
We show growth while EXP is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.58%
Similar asset growth to EXP's 2.38%. Walter Schloss finds parallel expansions or investment rates.
-1.91%
We have a declining book value while EXP shows 4.77%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
11.01%
We have some new debt while EXP reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-5.17%
We cut SG&A while EXP invests at 6.06%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.